Lead	O
Exposure	O
Induces	O
Weight	O
Gain	O
in	O
Adult	O
Rats	B-OG
,	O
Accompanied	O
by	O
DNA	O
Hypermethylation	O

Competing	O
Interests	O
:	O
The	O
authors	O
have	O
declared	O
that	O
no	O
competing	O
interests	O
exist	O
.	O

Conceptualization	O
:	O
YL	O
LY	O
HS	O
NW	O
.	O
Data	O
curation	O
:	O
HS	O
.	O
Formal	O
analysis	O
:	O
HS	O
NW	O
.	O
Funding	O
acquisition	O
:	O
YL	O
HZ	O
NW	O
.	O
Investigation	O
:	O
HS	O
NW	O
XN	O
CC	O
.	O
Methodology	O
:	O
HS	O
NW	O
XN	O
.	O
Project	O
administration	O
:	O
HS	O
NW	O
XN	O
LZ	O
ZC	O
ML	O
.	O
Resources	O
:	O
HS	O
NW	O
QL	O
ZC	O
.	O
Software	O
:	O
NW	O
.	O
Supervision	O
:	O
YL	O
LY	O
.	O
Validation	O
:	O
YL	O
JC	O
HZ	O
FX	O
.	O
Visualization	O
:	O
HS	O
.	O
Writing	O
–	O
original	O
draft	O
:	O
HS	O
NW	O
.	O
Writing	O
–	O
review	O
&	O
editing	O
:	O
FX	O
YL	O
JC	O
.	O

Objective	O

Previous	O
studies	O
have	O
revealed	O
the	O
association	O
of	O
lead	O
(	O
Pb	O
)	O
exposure	O
with	O
obesity	B-DS
.	O

DNA	O
methylation	O
alteration	O
has	O
been	O
suggested	O
to	O
be	O
one	O
of	O
the	O
regulatory	O
mechanisms	O
of	O
obesity	B-DS
.	O

We	O
aimed	O
to	O
explore	O
whether	O
Pb	O
exposure	O
is	O
related	O
with	O
weight	O
gain	O
and	O
DNA	O
methylation	O
alteration	O
.	O

Methods	O

Male	O
adult	O
8	O
week	O
Wistar	B-OG
rats	I-OG
were	O
divided	O
into	O
5	O
groups	O
:	O
the	O
normal	O
chow	O
diet	O
(	O
NCD	O
);	O
the	O
NCD	O
+	O
0	O
.	O
05	O
%	O
Pb	O
;	O
the	O
NCD	O
+	O
0	O
.	O
15	O
%	O
Pb	O
;	O
the	O
NCD	O
+	O
0	O
.	O
45	O
%	O
Pb	O
and	O
the	O
high	O
fat	O
diet	O
.	O

Rats	B-OG
were	O
exposed	O
to	O
different	O
dosages	O
of	O
Pb	O
through	O
drinking	O
water	O
for	O
21	O
weeks	O
.	O

Body	O
weight	O
,	O
fasted	O
blood	O
glucose	O
level	O
,	O
fasted	O
insulin	B-GP
level	O
,	O
homeostasis	O
assessment	O
of	O
insulin	B-DS
resistance	I-DS
(	O
HOMA	O
-	O
IR	B-DS
)	O
index	O
and	O
lipid	O
profile	O
were	O
detected	O
.	O

Intra	O
-	O
peritoneal	O
glucose	O
tolerance	O
test	O
(	O
IPGTT	O
)	O
was	O
constructed	O
to	O
evaluate	O
the	O
glucose	O
tolerance	O
.	O

Lipid	O
accumulation	O
of	O
liver	O
was	O
detected	O
and	O
liver	O
DNA	O
underwent	O
whole	O
genome	O
bisulfite	O
sequencing	O
.	O

Results	O

The	O
NCD	O
+	O
0	O
.	O
05	O
%	O
Pb	O
group	O
had	O
significantly	O
greater	O
weight	O
,	O
HOMA	O
-	O
IR	B-DS
and	O
triglycerides	O
,	O
and	O
lower	O
glucose	B-DS
intolerance	I-DS
than	O
the	O
NCD	O
group	O
(	O
P	O
<	O
0	O
.	O
05	O
).	O

This	O
group	O
also	O
showed	O
hepatic	O
lipid	O
accumulation	O
.	O

These	O
metabolic	O
changes	O
were	O
not	O
observed	O
in	O
the	O
other	O
two	O
Pb	O
dosage	O
groups	O
.	O

Furthermore	O
,	O
DNA	O
hypermethylation	O
extended	O
along	O
pathways	O
related	O
to	O
glucose	O
and	O
lipid	O
metabolism	O
in	O
NCD	O
+	O
0	O
.	O
05	O
%	O
Pb	O
group	O
.	O

Conclusion	O

Pb	O
exposure	O
resulted	O
in	O
dose	O
-	O
specific	O
weight	O
gain	O
in	O
adult	O
Wistar	B-OG
rats	I-OG
,	O
accompanied	O
by	O
alteration	O
of	O
DNA	O
methylation	O
.	O

Introduction	O

The	O
prevalence	O
of	O
overweight	O
and	O
obesity	B-DS
has	O
drawn	O
worldwide	O
attention	O
in	O
all	O
geographic	O
areas	O
during	O
last	O
two	O
decades	O
.	O

In	O
USA	O
,	O
the	O
combined	O
prevalence	O
of	O
overweight	O
and	O
obesity	B-DS
had	O
risen	O
from	O
14	O
.	O
5	O
%	O
to	O
35	O
.	O
1	O
%	O
in	O
adults	O
[	O
1	O
],	O
which	O
is	O
similar	O
to	O
growth	O
seen	O
in	O
China	O
from	O
14	O
.	O
6	O
%	O
to	O
32	O
.	O
3	O
%,	O
due	O
to	O
economic	O
boom	O
and	O
lifestyle	O
changes	O
[	O
2	O
].	O

However	O
,	O
environmental	O
factors	O
are	O
attributed	O
to	O
the	O
rising	O
prevalence	O
of	O
obesity	B-DS
,	O
too	O
.	O

Endocrine	O
disrupting	O
chemicals	O
,	O
such	O
as	O
heavy	O
metals	O
,	O
have	O
been	O
confirmed	O
to	O
be	O
associated	O
with	O
obesity	B-DS
[	O
3	O
].	O

Lead	O
(	O
Pb	O
)	O
is	O
a	O
kind	O
of	O
heavy	O
metal	O
widely	O
used	O
in	O
gasoline	O
and	O
lead	O
-	O
acid	O
battery	O
industries	O
[	O
2	O
].	O

Pb	O
pollutants	O
may	O
be	O
released	O
as	O
air	O
pollution	O
or	O
waste	O
mixtures	O
into	O
soil	O
and	O
waterways	O
in	O
the	O
process	O
of	O
manufacturing	O
,	O
which	O
were	O
then	O
up	O
-	O
taken	O
through	O
food	O
,	O
water	O
and	O
air	O
[	O
4	O
].	O

Lead	B-DS
poisoning	I-DS
mainly	O
caused	O
brain	B-DS
and	I-DS
neurology	I-DS
defects	I-DS
,	O
namely	O
cognitive	B-DS
disorder	I-DS
,	O
movement	B-DS
and	I-DS
coordination	I-DS
impairment	I-DS
,	O
hearing	O
and	O
visual	B-DS
disturbance	I-DS
[	O
5	O
].	O
Recent	O
studies	O
have	O
suggested	O
Pb	O
as	O
an	O
endocrine	O
disrupting	O
chemical	O
.	O

Pb	O
is	O
not	O
only	O
associated	O
with	O
late	O
-	O
onset	O
puberty	O
[	O
6	O
,	O
7	O
]	O
but	O
also	O
acts	O
on	O
hypothalamic	O
-	O
pituitary	O
-	O
adrenal	O
(	O
HPA	O
)	O
axis	O
,	O
thus	O
causing	O
high	O
stress	O
-	O
related	O
cortisol	O
levels	O
[	O
8	O
–	O
10	O
].	O

In	O
addition	O
,	O
high	O
bone	O
turnover	O
is	O
related	O
with	O
Pb	O
exposure	O
[	O
11	O
].	O
Furthermore	O
,	O
a	O
lot	O
of	O
studies	O
have	O
investigated	O
the	O
relationship	O
between	O
early	O
Pb	O
exposure	O
with	O
BMI	O
and	O
obesity	B-DS
,	O
and	O
the	O
results	O
were	O
inconclusive	O
.	O

Some	O
epidemiology	O
as	O
well	O
as	O
animal	B-OG
studies	O
revealed	O
that	O
maternal	O
or	O
adolescent	O
lead	O
exposure	O
caused	O
prolonged	O
obesity	B-DS
that	O
persisted	O
into	O
adults	O
[	O
4	O
,	O
5	O
,	O
12	O
,	O
13	O
],	O
whereas	O
others	O
indicated	O
mother	O
lead	O
level	O
was	O
associated	O
with	O
low	O
birth	O
weight	O
[	O
14	O
,	O
15	O
].	O

However	O
,	O
little	O
has	O
concentrated	O
on	O
the	O
effects	O
of	O
adult	O
Pb	O
exposure	O
on	O
obesity	B-DS
.	O

Our	O
previous	O
investigation	O
from	O
the	O
cross	O
-	O
sectional	O
study	O
revealed	O
positive	O
relationship	O
between	O
blood	O
lead	O
level	O
(	O
BLL	O
)	O
and	O
obesity	B-DS
in	O
adults	O
[	O
2	O
].	O

Thus	O
,	O
it	O
is	O
essential	O
to	O
establish	O
an	O
animal	B-OG
model	O
to	O
explore	O
the	O
underlying	O
mechanisms	O
.	O

There	O
is	O
a	O
growing	O
recognition	O
of	O
the	O
impact	O
of	O
environmental	O
factors	O
such	O
as	O
heavy	O
metals	O
,	O
diet	O
and	O
stress	O
on	O
the	O
epigenetic	O
regulation	O
of	O
gene	O
expression	O
,	O
especially	O
in	O
early	O
life	O
or	O
at	O
maternal	O
stage	O
[	O
16	O
].	O

DNA	O
Methylation	O
is	O
one	O
of	O
the	O
most	O
common	O
epigenetic	O
events	O
.	O

Some	O
research	O
has	O
confirmed	O
that	O
both	O
obesity	B-DS
and	O
type	B-DS
2	I-DS
diabetes	I-DS
were	O
accompanied	O
by	O
DNA	O
methylation	O
changes	O
of	O
some	O
metabolic	O
-	O
related	O
genes	O
[	O
17	O
–	O
19	O
].	O

In	O
one	O
study	O
,	O
various	O
levels	O
of	O
maternal	O
lead	O
exposure	O
resulted	O
in	O
the	O
fur	O
color	O
changes	O
of	O
offspring	O
as	O
well	O
as	O
methylation	O
level	O
changes	O
of	O
some	O
gene	O
locus	O
and	O
imprinted	O
genes	O
that	O
determined	O
fur	O
color	O
[	O
4	O
].	O

In	O
our	O
study	O
,	O
we	O
constructed	O
different	O
levels	O
of	O
leaded	O
water	O
on	O
adult	O
rats	B-OG
,	O
to	O
observe	O
the	O
association	O
of	O
Pb	O
and	O
weight	O
gain	O
and	O
other	O
metabolic	O
parameters	O
.	O

Furthermore	O
,	O
using	O
liver	O
samples	O
,	O
we	O
performed	O
a	O
genome	O
-	O
wide	O
methylome	O
analysis	O
to	O
observe	O
DNA	O
methylation	O
signatures	O
.	O

Materials	O
and	O
Methods	O

Animal	B-OG
experiments	O

Twenty	O
-	O
five	O
male	O
8	O
-	O
week	O
-	O
old	O
Wistar	B-OG
rats	I-OG
were	O
purchased	O
from	O
SLAC	O
Laboratories	O
,	O
SIBS	O
,	O
Shanghai	O
,	O
China	O
.	O

Animals	B-OG
were	O
housed	O
at	O
an	O
ambient	O
temperature	O
of	O
22	O
±	O
2	O
°	O
C	O
and	O
maintained	O
under	O
a	O
normal	O
12	O
hours	O
light	O
/	O
dark	O
cycle	O
and	O
allowed	O
access	O
to	O
food	O
and	O
water	O
ad	O
libitum	O
.	O

After	O
one	O
week	O
of	O
acclimatization	O
,	O
rats	B-OG
were	O
randomly	O
assigned	O
to	O
two	O
groups	O
with	O
one	O
(	O
N	O
=	O
20	O
)	O
conventionally	O
fed	O
with	O
normal	O
chow	O
diets	O
(	O
NCD	O
;	O
containing	O
10	O
%	O
fat	O
)	O
and	O
the	O
other	O
(	O
N	O
=	O
5	O
)	O
with	O
high	O
fat	O
diets	O
(	O
HFD	O
;	O
containing	O
40	O
%	O
fat	O
),	O
the	O
former	O
group	O
was	O
then	O
divided	O
into	O
4	O
sub	O
-	O
groups	O
:	O
NCD	O
(	O
N	O
=	O
5	O
);	O
NCD	O
+	O
0	O
.	O
05	O
%	O
Pb	O
(	O
N	O
=	O
5	O
);	O
NCD	O
+	O
0	O
.	O
15	O
%	O
Pb	O
(	O
N	O
=	O
5	O
);	O
NCD	O
+	O
0	O
.	O
45	O
%	O
Pb	O
(	O
N	O
=	O
5	O
).	O

Leaded	O
water	O
was	O
made	O
by	O
dissolving	O
Lead	O
(	O
Ⅱ	O
)	O
acetate	O
trihydrate	O
((	O
CH3COO	O
)	O
2Pb	O
.	O
3H20	O
)	O
(	O
Sangon	O
biotech	O
,	O
shanghai	O
)	O
in	O
distilled	O
water	O
.	O

Animal	B-OG
treatment	O
lasted	O
for	O
21	O
weeks	O
.	O

Body	O
weight	O
and	O
FBG	O
were	O
measured	O
every	O
two	O
weeks	O
at	O
the	O
overnight	O
fasting	O
condition	O
.	O

For	O
the	O
IPGTT	O
,	O
the	O
animals	B-OG
were	O
intra	O
-	O
peritoneally	O
injected	O
with	O
glucose	O
of	O
2g	O
/	O
kg	O
body	O
weight	O
(	O
Sigma	O
)	O
after	O
12	O
h	O
of	O
fasting	O
,	O
and	O
blood	O
glucose	O
levels	O
were	O
measured	O
at	O
baseline	O
and	O
at	O
time	O
points	O
of	O
15min	O
,	O
30min	O
,	O
60min	O
,	O
90min	O
,	O
120min	O
after	O
glucose	O
injection	O
by	O
an	O
electronic	O
glucometer	O
(	O
Terumo	O
,	O
Tokyo	O
,	O
Japan	O
).	O

Animals	B-OG
were	O
sacrificed	O
by	O
anesthesia	O
,	O
bones	O
were	O
obtained	O
immediately	O
and	O
bone	O
lead	O
concentration	O
was	O
detected	O
with	O
inductively	O
coupled	O
plasma	O
atomic	O
emission	O
spectroscopy	O
.	O

All	O
the	O
animal	B-OG
experiments	O
were	O
carried	O
out	O
in	O
accordance	O
with	O
the	O
Guidelines	O
for	O
Care	O
and	O
Use	O
of	O
Laboratory	O
Animals	B-OG
of	O
Shanghai	O
Laboratory	O
Animal	B-OG
Center	O
(	O
SLAC	O
),	O
Chinese	O
Academy	O
of	O
Sciences	O
,	O
Shanghai	O
,	O
China	O
.	O

All	O
the	O
protocols	O
were	O
approved	O
by	O
the	O
Institutional	O
Animal	B-OG
Care	O
and	O
Use	O
Committee	O
of	O
SLAC	O
(	O
No	O
.	O
2011	O
–	O
007	O
).	O

We	O
have	O
made	O
all	O
efforts	O
to	O
minimize	O
animal	B-OG
suffering	O
.	O

Measurement	O
of	O
insulin	B-GP
and	O
biochemical	O
indexes	O

Tail	O
blood	O
was	O
separately	O
collected	O
from	O
the	O
caudal	O
vein	O
following	O
overnight	O
fasting	O
at	O
the	O
end	O
of	O
the	O
experiment	O
for	O
detection	O
of	O
insulin	B-GP
and	O
biochemical	O
profiles	O
.	O

Alanine	B-GP
aminotransferase	I-GP
(	O
ALT	B-GP
),	O
aspartate	B-GP
transaminase	I-GP
(	O
AST	B-GP
),	O
triglycerides	O
(	O
TG	O
),	O
total	O
cholesterol	O
(	O
TC	O
),	O
free	O
fatty	O
acid	O
(	O
FFA	O
)	O
and	O
low	O
-	O
density	O
lipoprotein	O
cholesterol	O
(	O
LDL	O
-	O
C	O
)	O
levels	O
were	O
detected	O
with	O
Siemens	O
Dimension	O
MAX	O
(	O
Siemens	O
Healthcare	O
Diagnostics	O
Inc	O
);	O
FSI	O
was	O
assessed	O
with	O
ELISA	O
kits	O
(	O
Shibayaji	O
,	O
Japan	O
);	O
HOMA	O
-	O
IR	B-DS
index	O
was	O
calculated	O
according	O
to	O
the	O
formula	O
:	O
FBG	O
*	O
FINS	O
/	O
22	O
.	O
5	O
.	O

Oil	O
red	O
staining	O
of	O
liver	O

After	O
the	O
rats	B-OG
were	O
sacrificed	O
,	O
the	O
right	O
lateral	O
lobule	O
of	O
the	O
livers	O
was	O
removed	O
and	O
subsequently	O
fixed	O
in	O
phosphate	O
-	O
buffered	O
10	O
%	O
formalin	O
.	O

The	O
fixed	O
liver	O
was	O
embedded	O
in	O
paraffin	O
blocks	O
and	O
were	O
sliced	O
and	O
stained	O
with	O
oil	O
red	O
to	O
evaluate	O
lipid	O
droplets	O
.	O

Genomic	O
DNA	O
isolation	O
and	O
WGBS	O
library	O
construction	O

Two	O
samples	O
were	O
randomly	O
selected	O
from	O
control	O
group	O
as	O
well	O
as	O
0	O
.	O
05	O
%	O
Pb	O
group	O
,	O
separately	O
.	O
Genomic	O
DNA	O
was	O
isolated	O
and	O
purified	O
from	O
25	O
mg	O
of	O
frozen	O
liver	O
tissue	O
with	O
the	O
DNeasy	O
Tissue	O
Kit	O
(	O
Qiagen	O
,	O
Germany	O
,	O
cat	O
.	O
no	O
.	O
51306	O
)	O
according	O
to	O
the	O
manufacturer	O
'	O
s	O
protocol	O
.	O

DNA	O
concentration	O
was	O
assessed	O
using	O
a	O
ND1000	O
spectrophotometer	O
(	O
NanoDrop	O
Technology	O
),	O
and	O
DNA	O
quality	O
was	O
assessed	O
by	O
electrophoresis	O
using	O
a	O
1	O
%	O
agarose	O
gel	O
.	O

3ug	O
of	O
genomic	O
DNA	O
were	O
broken	O
into	O
fragments	O
by	O
Covaris	O
S2	O
system	O
(	O
Covaris	O
,	O
MA	O
)	O
for	O
52	O
seconds	O
with	O
20	O
%	O
duty	O
cycle	O
,	O
level	O
5	O
intensity	O
and	O
200	O
cycles	O
per	O
burst	O
.	O

Fragmented	O
DNA	O
were	O
purified	O
by	O
Ampure	O
XP	O
Beads	O
(	O
Beckman	O
Coulter	O
,	O
CA	O
)	O
and	O
the	O
fragments	O
were	O
end	O
-	O
repaired	O
,	O
and	O
a	O
single	O
A	O
nucleotide	O
was	O
added	O
to	O
the	O
3	O
'	O
ends	O
of	O
the	O
fragments	O
in	O
preparation	O
for	O
ligation	O
to	O
a	O
methylated	O
adapter	O
(	O
Illumina	O
,	O
CA	O
)	O
with	O
a	O
single	O
-	O
base	O
T	O
overhang	O
.	O

The	O
ligation	O
products	O
were	O
purified	O
and	O
size	O
-	O
selected	O
(	O
300	O
-	O
400bp	O
)	O
using	O
agarose	O
gel	O
electrophoresis	O
(	O
Qiagen	O
Minelute	O
Gel	O
Extraction	O
Kit	O
).	O

DNA	O
was	O
modified	O
with	O
sodium	O
bisulfite	O
to	O
convert	O
unmethylated	O
cytosine	O
to	O
uracil	O
using	O
the	O
Zymo	O
Gold	O
methylation	O
kit	O
(	O
Zymo	O
Research	O
,	O
CA	O
)	O
according	O
to	O
the	O
manufacturer	O
'	O
s	O
protocol	O
and	O
then	O
purified	O
.	O

The	O
purified	O
converted	O
DNA	O
was	O
amplified	O
with	O
PfuTurbo	O
Cx	O
Hotstart	O
DNA	B-GP
Polymerase	I-GP
(	O
Agilent	O
Technologies	O
,	O
CA	O
)	O
and	O
was	O
purified	O
again	O
using	O
AMPure	O
XP	O
beads	O
.	O

Library	O
quality	O
was	O
monitored	O
using	O
the	O
Agilent	O
2100	O
Bio	O
-	O
Analyzer	O
(	O
Agilent	O
)	O
and	O
KAPA	O
Library	O
Quantification	O
Kit	O
(	O
Kapa	O
Biosystem	O
).	O

Paired	O
-	O
end	O
sequencing	O
(	O
2	O
×	O
100	O
bp	O
)	O
was	O
then	O
carried	O
out	O
using	O
the	O
Illumina	O
Hi	O
-	O
Seq	O
2000	O
.	O

Whole	O
-	O
genome	O
methylation	O
analysis	O

Identification	O
of	O
methylated	O
cytosines	O

After	O
sequencing	O
,	O
raw	O
data	O
were	O
filtered	O
into	O
clean	O
data	O
by	O
removing	O
pollution	O
reads	O
,	O
low	O
quality	O
reads	O
and	O
Adapters	O
.	O

FASTqc	O
software	O
was	O
used	O
to	O
assess	O
sequencing	O
accuracy	O
of	O
the	O
clean	O
data	O
.	O

The	O
sequencing	O
error	O
rates	O
were	O
controlled	O
lower	O
than	O
5	O
%.	O

Clean	O
data	O
were	O
mapped	O
to	O
the	O
reference	O
genome	O
of	O
rats	B-OG
using	O
in	O
silico	O
bisulfite	O
conversion	O
algorithm	O
with	O
Bismark	O
software	O
.	O

Reads	O
with	O
methylated	O
position	O
were	O
reported	O
when	O
sequencing	O
depth	O
was	O
≥	O
1	O
.	O

We	O
used	O
the	O
bulk	O
fractional	O
methylation	O
of	O
mitochondria	O
DNA	O
to	O
measure	O
the	O
rate	O
of	O
false	O
positives	O
.	O

The	O
methylation	O
level	O
of	O
an	O
individual	O
cytosine	O
was	O
calculated	O
from	O
the	O
number	O
of	O
sequenced	O
cytosines	O
divided	O
by	O
the	O
total	O
read	O
depth	O
,	O
i	O
.	O
e	O
.	O
(	O
mC	O
)/(	O
mC	O
+	O
non	O
-	O
mC	O
).	O

The	O
methylation	O
level	O
of	O
a	O
region	O
,	O
named	O
“	O
bulk	O
methylation	O
level	O
”,	O
which	O
was	O
calculated	O
from	O
(	O
mC	O
)/(	O
mC	O
+	O
non	O
-	O
mC	O
).	O

mC	O
and	O
non	O
-	O
mC	O
referred	O
to	O
the	O
number	O
of	O
methylated	O
and	O
unmethylated	O
cytosines	O
,	O
respectively	O
,	O
in	O
this	O
region	O
.	O

The	O
cytosine	O
methylation	O
level	O
covered	O
by	O
more	O
than	O
5	O
reads	O
were	O
used	O
to	O
calculate	O
DNA	O
methylation	O
levels	O
of	O
whole	O
genome	O
and	O
specific	O
genetic	O
elements	O
such	O
as	O
TTS	O
,	O
TSS	O
,	O
CDS	O
,	O
transposon	O
element	O
etc	O
.	O

TSS	O
was	O
defined	O
as	O
2000bp	O
of	O
upstream	O
and	O
downstream	O
region	O
of	O
gene	O
start	O
sites	O
.	O

TTS	O
was	O
defined	O
as	O
2000bp	O
of	O
upstream	O
and	O
downstream	O
region	O
of	O
gene	O
termination	O
site	O
.	O

Methylation	O
signal	O
intensity	O
values	O
of	O
whole	O
genome	O
were	O
drawn	O
in	O
a	O
circular	O
view	O
using	O
CIRCOS	O
visualization	O
software	O
.	O

Identification	O
and	O
enrichment	O
of	O
differentially	O
methylated	O
regions	O
(	O
DMRs	O
)	O
of	O
genes	O

To	O
identify	O
genes	O
with	O
significant	O
differences	O
in	O
DNA	O
methylation	O
between	O
two	O
groups	O
,	O
we	O
locked	O
in	O
TSS	O
regions	O
of	O
genes	O
.	O

Biological	O
replicates	O
of	O
each	O
group	O
were	O
merged	O
,	O
and	O
afterwards	O
genomic	O
sites	O
with	O
methylation	O
cytosine	O
covered	O
by	O
more	O
than	O
2	O
reads	O
were	O
analyzed	O
with	O
DMR	O
caller	O
package	O
of	O
R	O
software	O
.	O

P	O
values	O
were	O
calculated	O
by	O
Fisher	O
’	O
s	O
exact	O
test	O
,	O
and	O
then	O
FDR	O
correction	O
was	O
performed	O
.	O

Cytosines	O
with	O
FDR	O
(<	O
0	O
.	O
05	O
)	O
and	O
methylation	O
differences	O
of	O
at	O
least	O
0	O
.	O
05	O
for	O
CG	O
contexts	O
were	O
identified	O
as	O
differentially	O
methylated	O
regions	O
.	O

Single	O
reads	O
of	O
potential	O
DMRs	O
were	O
analyzed	O
using	O
the	O
Integrative	O
Genomic	O
Viewer	O
(	O
IGV	O
)	O
Browser	O
.	O

We	O
processed	O
KEGG	O
pathway	O
enrichment	O
of	O
different	O
methylated	O
genes	O
and	O
calculated	O
the	O
significance	O
of	O
every	O
KEGG	O
pathway	O
with	O
hypergeometric	O
distribution	O
testing	O
method	O
.	O

A	O
small	O
P	O
value	O
indicated	O
differential	O
gene	O
enrichment	O
in	O
specific	O
KEGG	O
pathway	O
.	O

Statistics	O
analysis	O

Data	O
were	O
presented	O
as	O
mean	O
±	O
SEM	O
.	O

The	O
overall	O
differences	O
between	O
treatment	O
groups	O
were	O
compared	O
using	O
one	O
-	O
way	O
analysis	O
of	O
variance	O
(	O
ANOVA	O
),	O
followed	O
by	O
Tukey	O
’	O
s	O
multiple	O
comparison	O
test	O
,	O
and	O
LSD	O
,	O
with	O
or	O
without	O
repeated	O
measures	O
.	O

P	O
<	O
0	O
.	O
05	O
was	O
considered	O
to	O
be	O
statistically	O
significant	O
.	O

GraphPad	O
Prism	O
,	O
Version	O
5	O
(	O
GraphPad	O
Software	O
)	O
was	O
used	O
for	O
all	O
statistical	O
analyses	O
.	O

Results	O

Pb	O
was	O
deposited	O
in	O
femur	O
of	O
rats	B-OG
drinking	O
leaded	O
water	O
for	O
21	O
weeks	O

Table	O
1	O
reveals	O
the	O
cumulative	O
bone	O
Pb	O
deposition	O
in	O
each	O
group	O
.	O

Pb	O
was	O
scarcely	O
detectable	O
in	O
femur	O
of	O
both	O
NCD	O
and	O
HFD	O
group	O
.	O

However	O
,	O
significant	O
Pb	O
accumulations	O
were	O
observed	O
in	O
Pb	O
exposure	O
groups	O
(	O
P	O
<	O
0	O
.	O
05	O
).	O

The	O
mean	O
Pb	O
content	O
was	O
56	O
.	O
25	O
±	O
7	O
.	O
47	O
ng	O
/	O
mg	O
in	O
NCD	O
+	O
0	O
.	O
05	O
%	O
Pb	O
group	O
,	O
which	O
was	O
tripled	O
in	O
0	O
.	O
15	O
%	O
Pb	O
(	O
160	O
.	O
50	O
±	O
14	O
.	O
15	O
ng	O
/	O
mg	O
)	O
exposure	O
group	O
.	O

Interestingly	O
,	O
Pb	O
content	O
in	O
NCD	O
+	O
0	O
.	O
45	O
%	O
Pb	O
group	O
(	O
189	O
.	O
30	O
±	O
18	O
.	O
22	O
ng	O
/	O
mg	O
)	O
did	O
not	O
exhibit	O
the	O
same	O
increasing	O
pattern	O
.	O

Bone	O
Pb	O
levels	O
in	O
rats	B-OG
(	O
ng	O
Pb	O
/	O
mg	O
dry	O
wt	O
of	O
femur	O
)	O
at	O
21	O
weeks	O
.	O

NCD	O

NCD	O
+	O
0	O
.	O
05	O
%	O
Pb	O

NCD	O
+	O
0	O
.	O
15	O
%	O
Pb	O

NCD	O
+	O
0	O
.	O
45	O
%	O
Pb	O

HFD	O

Bone	O
lead	O
,	O
ng	O
/	O
mg	O

≤	O
1	O

56	O
.	O
25	O
±	O
7	O
.	O
47a	O

160	O
.	O
50	O
±	O
14	O
.	O
15a	O

189	O
.	O
30	O
±	O
18	O
.	O
22a	O

≤	O
1	O

Data	O
are	O
expressed	O
as	O
mean	O
±	O
SEM	O
.	O

Pb	O
was	O
determined	O
in	O
thigh	O
bone	O
by	O
inductively	O
coupled	O
plasma	O
atomic	O
emission	O
spectroscopy	O
.	O

a	O
P	O
<	O
0	O
.	O
05	O
vs	O
.	O
NCD	O
by	O
one	O
-	O
way	O
ANOVA	O
.	O

0	O
.	O
05	O
%	O
Pb	O
resulted	O
in	O
weight	O
gain	O

Weight	O
gains	O
(	O
Fig	O
1A	O
)	O
were	O
observed	O
in	O
all	O
groups	O
.	O

Rats	B-OG
of	O
HFD	O
accumulated	O
significantly	O
more	O
weight	O
than	O
that	O
of	O
NCD	O
at	O
the	O
end	O
of	O
21	O
weeks	O
(	O
P	O
<	O
0	O
.	O
05	O
).	O

Both	O
the	O
NCD	O
+	O
0	O
.	O
15	O
%	O
Pb	O
and	O
NCD	O
+	O
0	O
.	O
45	O
%	O
Pb	O
groups	O
exhibited	O
less	O
weight	O
gain	O
in	O
comparison	O
with	O
NCD	O
group	O
(	O
P	O
<	O
0	O
.	O
05	O
).	O

Notably	O
,	O
only	O
exposure	O
to	O
0	O
.	O
05	O
%	O
Pb	O
contributed	O
to	O
increased	O
weight	O
compared	O
with	O
the	O
NCD	O
control	O
group	O
(	O
P	O
<	O
0	O
.	O
05	O
).	O

Body	O
Weight	O
and	O
Fasted	O
glucose	O
levels	O
of	O
rats	B-OG
after	O
Pb	O
exposure	O
.	O

(	O
a	O
)	O
Body	O
weight	O
.	O

(	O
b	O
)	O
Fasted	O
glucose	O
level	O
.	O

Data	O
are	O
expressed	O
as	O
mean	O
±	O
SEM	O
.	O
*	O
P	O
<	O
0	O
.	O
05	O
vs	O
.	O
NCD	O
by	O
one	O
-	O
way	O
ANOVA	O
.	O

0	O
.	O
05	O
%	O
Pb	O
resulted	O
in	O
glucose	B-DS
intolerance	I-DS
and	O
insulin	B-DS
resistance	I-DS
of	O
rats	B-OG

Though	O
no	O
significant	O
difference	O
in	O
fasted	O
blood	O
glucose	O
level	O
(	O
Fig	O
1B	O
)	O
was	O
observed	O
across	O
different	O
groups	O
,	O
in	O
order	O
to	O
evaluate	O
glucose	O
homeostasis	O
,	O
we	O
further	O
conducted	O
IPGTT	O
at	O
the	O
20th	O
week	O
of	O
the	O
study	O
.	O

The	O
curves	O
of	O
HFD	O
group	O
remained	O
at	O
the	O
top	O
during	O
the	O
120	O
minutes	O
(	O
Fig	O
2A	O
).	O

Meanwhile	O
in	O
the	O
NCD	O
groups	O
,	O
0	O
.	O
05	O
%	O
Pb	O
resulted	O
in	O
higher	O
peaking	O
glucose	O
level	O
at	O
the	O
15	O
min	O
time	O
point	O
compared	O
to	O
controls	O
.	O

To	O
quantify	O
glucose	O
tolerance	O
,	O
we	O
calculated	O
the	O
area	O
under	O
curve	O
(	O
AUC	O
)	O
for	O
all	O
treatment	O
groups	O
.	O

Exposure	O
to	O
Pb	O
increased	O
the	O
average	O
AUC	O
in	O
NCD	O
groups	O
(	O
Fig	O
2B	O
).	O

Among	O
the	O
NCD	O
groups	O
,	O
the	O
NCD	O
+	O
0	O
.	O
05	O
%	O
Pb	O
group	O
showed	O
a	O
significant	O
higher	O
AUC	O
than	O
NCD	O
control	O
(	O
P	O
<	O
0	O
.	O
05	O
),	O
which	O
was	O
similar	O
to	O
the	O
AUC	O
of	O
HFD	O
.	O

The	O
AUCs	O
of	O
the	O
other	O
two	O
Pb	O
dosages	O
(	O
0	O
.	O
15	O
%	O
and	O
0	O
.	O
45	O
%)	O
were	O
not	O
significantly	O
larger	O
than	O
that	O
of	O
the	O
NCD	O
control	O
group	O
.	O

Glucose	B-DS
intolerance	I-DS
and	O
insulin	B-DS
resistance	I-DS
were	O
observed	O
after	O
Pb	O
exposure	O
.	O

(	O
a	O
)	O
IPGTT	O
.	O
*	O
P	O
<	O
0	O
.	O
05	O
HFD	O
vs	O
.	O
NCD	O
;	O
#	O
P	O
<	O
0	O
.	O
05	O
NCD	O
+	O
0	O
.	O
05	O
%	O
Pb	O
vs	O
.	O
NCD	O
by	O
repeated	O
measures	O
data	O
ANOVA	O
.	O

(	O
b	O
)	O
AUC	O
of	O
IPGTT	O
.	O

(	O
c	O
)	O
Fasted	O
serum	O
insulin	B-GP
levels	O
.	O

(	O
d	O
)	O
HOMA	O
-	O
IR	B-DS
indexes	O
.	O

Data	O
are	O
expressed	O
as	O
mean	O
±	O
SEM	O
.	O

(	O
b	O
),	O
(	O
c	O
),	O
(	O
d	O
)*	O
P	O
<	O
0	O
.	O
05	O
vs	O
.	O
NCD	O
by	O
one	O
-	O
way	O
ANOVA	O
.	O

Moreover	O
,	O
a	O
significantly	O
elevated	O
fasted	O
insulin	B-GP
level	O
(	O
FSI	O
)	O
was	O
observed	O
in	O
the	O
NCD	O
+	O
0	O
.	O
05	O
%	O
Pb	O
group	O
(	O
Fig	O
2C	O
)	O
(	O
P	O
<	O
0	O
.	O
05	O
),	O
which	O
was	O
even	O
higher	O
than	O
in	O
the	O
HFD	O
group	O
(	O
P	O
<	O
0	O
.	O
05	O
).	O

The	O
HOMA	O
-	O
IR	B-DS
index	O
exhibited	O
the	O
same	O
patterns	O
(	O
Fig	O
2D	O
).	O

0	O
.	O
05	O
%	O
Pb	O
led	O
to	O
biochemical	O
changes	O

Alanine	B-GP
aminotransferase	I-GP
(	O
ALT	B-GP
)	O
and	O
aspartate	B-GP
aminotransferase	I-GP
(	O
AST	B-GP
)	O
were	O
detected	O
to	O
evaluate	O
liver	O
function	O
.	O

The	O
NCD	O
+	O
0	O
.	O
45	O
%	O
Pb	O
group	O
showed	O
slightly	O
higher	O
ALT	B-GP
and	O
AST	B-GP
level	O
than	O
others	O
,	O
indicating	O
high	O
Pb	O
dosage	O
exposure	O
might	O
result	O
in	O
liver	B-DS
damage	I-DS
(	O
Fig	O
3A	O
and	O
3B	O
),	O
though	O
the	O
differences	O
did	O
not	O
reach	O
significance	O
.	O

The	O
NCD	O
+	O
0	O
.	O
05	O
%	O
Pb	O
group	O
exhibited	O
significantly	O
higher	O
TG	O
level	O
(	O
Fig	O
3C	O
)	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
compared	O
to	O
other	O
NCD	O
groups	O
.	O

This	O
group	O
also	O
had	O
higher	O
low	O
-	O
density	O
lipoprotein	O
cholesterol	O
(	O
LDL	O
-	O
C	O
)	O
than	O
NCD	O
control	O
group	O
(	O
P	O
<	O
0	O
.	O
05	O
)	O
(	O
Fig	O
3E	O
).	O

Differences	O
were	O
not	O
observed	O
in	O
serum	O
total	O
cholesterol	O
(	O
TC	O
)	O
and	O
free	O
fatty	O
acid	O
(	O
FFA	O
)	O
levels	O
(	O
Fig	O
3D	O
and	O
3F	O
).	O

Biochemical	O
changes	O
after	O
Pb	O
exposure	O
.	O

(	O
a	O
)	O
Serum	O
ALT	B-GP
levels	O
;	O
(	O
b	O
)	O
Serum	O
AST	B-GP
levels	O
;	O
(	O
c	O
)	O
Serum	O
TG	O
levels	O
;	O
(	O
d	O
)	O
Serum	O
TC	O
levels	O
;	O
(	O
e	O
)	O
Serum	O
LDL	O
-	O
C	O
levels	O
;	O
(	O
f	O
)	O
Serum	O
FFA	O
levels	O
.	O
*	O
P	O
<	O
0	O
.	O
05	O
by	O
one	O
-	O
way	O
ANOVA	O
.	O

0	O
.	O
05	O
%	O
Pb	O
led	O
to	O
lipid	O
accumulation	O
of	O
liver	O

Oil	O
red	O
staining	O
showed	O
excessive	O
lipid	O
droplets	O
in	O
the	O
hepatocytes	O
of	O
rats	B-OG
fed	O
with	O
high	O
-	O
fat	O
diet	O
(	O
Fig	O
4	O
).	O

Meanwhile	O
,	O
increased	O
hepatic	O
triglyceride	O
contents	O
were	O
observed	O
in	O
0	O
.	O
05	O
%	O
Pb	O
treated	O
rats	B-OG
compared	O
to	O
the	O
NCD	O
control	O
rats	B-OG
.	O

Oil	O
red	O
staining	O
of	O
liver	O
.	O

Lipid	O
accumulation	O
was	O
observed	O
in	O
rats	B-OG
of	O
HFD	O
group	O
as	O
well	O
as	O
exposed	O
to	O
0	O
.	O
05	O
%	O
Pb	O
.	O

The	O
magnification	O
is	O
400	O
×.	O

Whole	O
genome	O
DNA	O
methylation	O
alteration	O
was	O
observed	O
in	O
0	O
.	O
05	O
%	O
Pb	O
exposed	O
rats	B-OG

The	O
WGBS	O
data	O
has	O
been	O
uploaded	O
to	O
GEO	O
(	O
Series	O
record	O
:	O
GSE89919	O
).	O
Significant	O
metabolic	O
changes	O
were	O
observed	O
in	O
the	O
NCD	O
+	O
0	O
.	O
05	O
%	O
Pb	O
group	O
,	O
thus	O
we	O
conducted	O
the	O
whole	O
genome	O
bisulfite	O
sequencing	O
of	O
liver	O
samples	O
in	O
both	O
the	O
NCD	O
+	O
0	O
.	O
05	O
%	O
Pb	O
group	O
and	O
the	O
NCD	O
control	O
group	O
.	O

As	O
was	O
observed	O
in	O
the	O
CIRCOS	O
map	O
(	O
Fig	O
5A	O
),	O
the	O
NCD	O
+	O
0	O
.	O
05	O
%	O
Pb	O
group	O
had	O
hypermethylation	O
at	O
the	O
whole	O
genome	O
level	O
,	O
compared	O
to	O
NCD	O
.	O

The	O
density	O
distribution	O
curves	O
revealed	O
that	O
unmethylated	O
CG	O
sites	O
were	O
reduced	O
and	O
100	O
%	O
mCG	O
sites	O
were	O
increased	O
after	O
0	O
.	O
05	O
%	O
Pb	O
treatment	O
(	O
S1	O
Fig	O
).	O

Furthermore	O
,	O
average	O
DNA	O
methylation	O
levels	O
were	O
all	O
elevated	O
in	O
specific	O
genetic	O
functional	O
elements	O
such	O
as	O
gene	O
,	O
intergenic	O
,	O
intron	O
,	O
extron	O
,	O
CpG	O
Island	O
as	O
well	O
as	O
repeated	O
elements	O
(	O
S2	O
Fig	O
).	O

The	O
profiling	O
analysis	O
revealed	O
the	O
overall	O
trend	O
of	O
DNA	O
methylation	O
in	O
different	O
regions	O
of	O
gene	O
,	O
transcription	O
start	O
site	O
(	O
TSS	O
)	O
and	O
transcription	O
terminal	O
site	O
(	O
TTS	O
)	O
sections	O
(	O
Fig	O
5B	O
–	O
5D	O
).	O

All	O
the	O
three	O
sections	O
showed	O
increased	O
methylation	O
levels	O
at	O
overall	O
length	O
,	O
although	O
there	O
were	O
small	O
differences	O
between	O
two	O
samples	O
of	O
the	O
same	O
group	O
.	O

DNA	O
methylation	O
files	O
of	O
liver	O
genome	O
for	O
NCD	O
+	O
0	O
.	O
05	O
%	O
Pb	O
group	O
compared	O
to	O
NCD	O
group	O
.	O

(	O
a	O
)	O
The	O
circus	O
map	O
;	O
(	O
b	O
)	O
The	O
profiling	O
of	O
TSS	O
region	O
;	O
(	O
c	O
)	O
The	O
profiling	O
of	O
gene	O
body	O
region	O
;	O
(	O
d	O
)	O
The	O
profiling	O
of	O
TTS	O
region	O
.	O

Differentially	O
methylated	O
genes	O
associated	O
with	O
glucose	O
and	O
lipid	O
metabolism	O
in	O
0	O
.	O
05	O
%	O
Pb	O
exposed	O
rats	B-OG

KEGG	O
pathway	O
enrichment	O
analysis	O
was	O
employed	O
to	O
identify	O
important	O
pathways	O
that	O
were	O
altered	O
in	O
Pb	O
exposure	O
group	O
compared	O
to	O
control	O
group	O
(	O
Fig	O
6A	O
).	O

Among	O
the	O
top	O
20	O
pathways	O
with	O
altered	O
DNA	O
methylation	O
were	O
metabolic	O
pathways	O
,	O
fatty	O
acid	O
elongation	O
pathway	O
as	O
well	O
as	O
TCA	O
cycle	O
pathway	O
.	O

DNA	O
methylation	O
enrichment	O
and	O
specific	O
genes	O
with	O
altered	O
DNA	O
methylation	O
for	O
NCD	O
+	O
0	O
.	O
05	O
%	O
Pb	O
group	O
compared	O
to	O
NCD	O
group	O
.	O

(	O
a	O
)	O
The	O
top	O
10	O
KEGG	O
pathways	O
changed	O
in	O
NCD	O
+	O
0	O
.	O
05	O
%	O
Pb	O
group	O
compared	O
to	O
NCD	O
group	O
.	O
P	O
values	O
were	O
derived	O
from	O
Fisher	O
’	O
s	O
Exact	O
Test	O
.	O

(	O
b	O
)	O
The	O
heat	O
map	O
of	O
specific	O
genes	O
related	O
with	O
glucose	O
and	O
lipid	O
metabolism	O
(	O
FDR	O
<	O
0	O
.	O
25	O
).	O

Difference	O
analysis	O
in	O
gene	O
methylation	O
aimed	O
at	O
TSS	O
region	O
indicated	O
that	O
a	O
total	O
of	O
2733	O
genes	O
experienced	O
DNA	O
methylation	O
changes	O
,	O
with	O
2320	O
hypermethylated	O
genes	O
and	O
413	O
hypomethylated	O
genes	O
(	O
S1	O
Table	O
).	O

A	O
heatmap	O
of	O
different	O
methylated	O
genes	O
related	O
to	O
lipid	O
and	O
glucose	O
metabolism	O
were	O
employed	O
(	O
Fig	O
6B	O
).	O

DNA	O
hypermethylation	O
was	O
observed	O
in	O
genes	O
related	O
to	O
fatty	O
acid	O
transport	O
and	O
synthesis	O
(	O
LDLR	B-GP
,	O
FATP	B-GP
,	O
Glyctk	B-GP
,	O
DGAT1	B-GP
and	O
DGAT2	B-GP
)	O
and	O
fatty	O
acid	O
oxidation	O
(	O
CPT	B-GP
-	I-GP
2	I-GP
,	O
MCAD	B-GP
,	O
CYP4A	B-GP
,	O
ACO	B-GP
).	O

In	O
addition	O
,	O
genes	O
related	O
to	O
VLDL	O
-	O
TG	O
assembling	O
(	O
MTTP	B-GP
and	O
APO	B-GP
-	I-GP
CⅢ	I-GP
,	O
APO	B-GP
-,	O
APO	B-GP
-	I-GP
Ⅳ	I-GP
)	O
and	O
the	O
transcription	O
factor	O
such	O
as	O
LXR	B-GP
and	O
SREBP	B-GP
-	I-GP
1c	I-GP
were	O
hypermethylated	O
.	O

Some	O
glucose	O
metabolism	O
related	O
genes	O
such	O
as	O
PKA	B-GP
and	O
AKT	B-GP
were	O
hypermethylated	O
.	O

PEPCK	B-GP
(	O
1	O
.	O
45	O
multiple	O
)	O
and	O
G6pase	B-GP
(	O
1	O
.	O
18	O
multiple	O
)	O
related	O
with	O
gluconeogenesis	O
were	O
also	O
hypermethylated	O
,	O
as	O
well	O
as	O
cholesterol	O
metabolism	O
genes	O
such	O
as	O
CYP51	B-GP
and	O
ACAT	B-GP
.	O

Discussion	O

In	O
our	O
research	O
,	O
we	O
found	O
that	O
0	O
.	O
05	O
%	O
Pb	O
water	O
exposure	O
brought	O
about	O
weight	O
gain	O
and	O
insulin	B-DS
resistance	I-DS
as	O
well	O
as	O
glucose	B-DS
intolerance	I-DS
in	O
the	O
NCD	O
rats	B-OG
,	O
accompanied	O
by	O
elevated	O
serum	O
TG	O
as	O
well	O
as	O
hepatic	O
lipid	O
accumulation	O
,	O
which	O
were	O
not	O
seen	O
in	O
the	O
other	O
two	O
dosages	O
(	O
0	O
.	O
15	O
%	O
and	O
0	O
.	O
45	O
%)	O
of	O
NCD	O
groups	O
.	O

Furthermore	O
,	O
compared	O
to	O
the	O
NCD	O
control	O
group	O
,	O
we	O
found	O
the	O
DNA	O
hypermethylation	O
extended	O
along	O
pathways	O
related	O
to	O
glucose	O
and	O
lipid	O
metabolism	O
in	O
the	O
NCD	O
+	O
0	O
.	O
05	O
%	O
Pb	O
group	O
.	O

These	O
results	O
indicated	O
that	O
0	O
.	O
05	O
%	O
Pb	O
may	O
induce	O
abnormal	O
metabolic	O
status	O
through	O
DNA	O
methylation	O
that	O
regulated	O
important	O
genes	O
involved	O
in	O
lipid	O
and	O
glucose	O
metabolism	O
.	O

As	O
a	O
kind	O
of	O
environmental	O
endocrine	O
disruptor	O
,	O
Pb	O
mimics	O
or	O
disrupts	O
hormone	O
function	O
at	O
low	O
doses	O
in	O
ways	O
not	O
predicted	O
by	O
high	O
-	O
dose	O
studies	O
[	O
20	O
].	O

Previous	O
animal	B-OG
studies	O
had	O
found	O
that	O
Pb	O
exposure	O
played	O
both	O
dose	O
-	O
specific	O
and	O
sex	O
-	O
specific	O
roles	O
in	O
body	O
weight	O
and	O
glucose	O
dys	O
-	O
metabolism	O
,	O
however	O
,	O
most	O
of	O
their	O
studies	O
focused	O
on	O
prenatal	O
Pb	O
exposure	O
,	O
and	O
the	O
effective	O
dose	O
and	O
conclusions	O
were	O
discrepant	O
.	O

In	O
one	O
study	O
,	O
prenatal	O
exposure	O
to	O
16ppm	O
and	O
32ppm	O
lead	O
water	O
caused	O
weight	O
gain	O
in	O
male	O
offspring	O
of	O
mice	B-OG
;	O
moreover	O
,	O
body	O
fat	O
and	O
FSI	O
level	O
as	O
well	O
as	O
HOMA	O
-	O
IR	B-DS
level	O
of	O
16ppm	O
male	O
offspring	O
were	O
significantly	O
increased	O
.	O

In	O
contrast	O
,	O
weight	O
gain	O
and	O
body	O
composition	O
changes	O
as	O
well	O
as	O
glucose	B-DS
intolerance	I-DS
were	O
not	O
seen	O
in	O
female	O
offspring	O
[	O
12	O
].	O

In	O
addition	O
,	O
a	O
linear	O
increase	O
in	O
mean	O
weight	O
with	O
increasing	O
pre	O
-	O
weaning	O
lead	O
exposure	O
in	O
male	O
offspring	O
was	O
observed	O
in	O
a	O
study	O
constructed	O
by	O
Faulk	O
et	O
al	O
.	O
[	O
4	O
].	O

The	O
effects	O
of	O
postnatal	O
Pb	O
exposure	O
on	O
metabolism	O
changes	O
were	O
inconclusive	O
.	O

Our	O
previous	O
epidemiology	O
study	O
revealed	O
a	O
positive	O
relationship	O
between	O
BLL	O
and	O
BMI	O
in	O
China	O
[	O
2	O
].	O

In	O
another	O
longitudinal	O
study	O
in	O
Boston	O
,	O
the	O
chronic	O
lead	O
exposure	O
in	O
childhood	O
may	O
result	O
in	O
obesity	B-DS
that	O
persists	O
into	O
adulthood	O
[	O
13	O
].	O

Whereas	O
Both	O
Miguel	O
A	O
.	O

Padilla	O
et	O
al	O
.	O
and	O
Franco	O
Scinicariello	O
et	O
al	O
.	O
reported	O
that	O
BLL	O
associated	O
with	O
lower	O
body	O
weight	O
in	O
adults	O
based	O
on	O
data	O
from	O
NHANES	O
[	O
1	O
,	O
21	O
].	O

In	O
another	O
study	O
,	O
no	O
association	O
was	O
found	O
between	O
BLL	O
and	O
BMI	O
in	O
adults	O
[	O
22	O
].	O

The	O
conflicting	O
results	O
may	O
be	O
due	O
to	O
ethnic	O
variations	O
as	O
well	O
as	O
different	O
BLL	O
of	O
the	O
study	O
population	O
.	O

In	O
one	O
animal	B-OG
study	O
,	O
gestational	O
exposure	O
from	O
27	O
to	O
109ppm	O
of	O
leaded	O
water	O
resulted	O
in	O
late	O
-	O
onset	O
obesity	B-DS
of	O
offspring	O
,	O
which	O
was	O
not	O
observed	O
in	O
the	O
same	O
-	O
dosage	O
treated	O
postnatal	O
groups	O
[	O
5	O
].	O

In	O
another	O
animal	B-OG
study	O
constructed	O
by	O
Eric	O
Beier	O
et	O
al	O
.	O
[	O
11	O
],	O
postnatal	O
50ppm	O
leaded	O
water	O
ingestion	O
had	O
no	O
effect	O
in	O
either	O
body	O
weight	O
or	O
fat	O
composition	O
of	O
mice	B-OG
,	O
whereas	O
it	O
caused	O
higher	O
fasted	O
glucose	O
level	O
and	O
elevated	O
leptin	B-GP
levels	O
.	O

Gestational	O
exposure	O
has	O
more	O
detrimental	O
effects	O
on	O
offspring	O
,	O
probably	O
due	O
to	O
high	O
efficiency	O
of	O
placenta	O
absorption	O
;	O
thus	O
postnatal	O
Pb	O
exposure	O
in	O
rats	B-OG
may	O
achieve	O
equivalent	O
effect	O
as	O
in	O
prenatal	O
ones	O
only	O
when	O
increasing	O
the	O
exposure	O
dosage	O
.	O

Therefore	O
,	O
higher	O
concentration	O
basis	O
and	O
gradients	O
were	O
set	O
in	O
our	O
experiment	O
compared	O
to	O
previous	O
studies	O
[	O
5	O
,	O
11	O
].	O

In	O
our	O
experiment	O
,	O
weight	O
gain	O
was	O
observed	O
in	O
the	O
NCD	O
rats	B-OG
received	O
0	O
.	O
05	O
%	O
lead	O
acetate	O
,	O
which	O
was	O
partly	O
in	O
accordance	O
with	O
our	O
previous	O
epidemiology	O
study	O
[	O
2	O
]	O
Glucose	O
tolerance	O
was	O
also	O
impaired	O
when	O
exposed	O
to	O
Pb	O
,	O
which	O
can	O
be	O
resulted	O
from	O
defects	O
in	O
insulin	B-GP
secretion	O
and	O
/	O
or	O
insulin	B-DS
sensitivity	I-DS
.	O

Both	O
fasting	O
insulin	B-GP
and	O
glucose	O
levels	O
were	O
elevated	O
in	O
the	O
NCD	O
+	O
0	O
.	O
05	O
%	O
Pb	O
group	O
,	O
indicating	O
excessive	O
hepatic	O
output	O
of	O
glucose	O
and	O
/	O
or	O
insensitivity	O
of	O
peripheral	O
tissues	O
especially	O
liver	O
,	O
which	O
could	O
also	O
be	O
verified	O
by	O
HOMA	O
-	O
IR	B-DS
index	O
.	O

Therefore	O
,	O
it	O
can	O
be	O
speculated	O
that	O
lead	O
may	O
disrupt	O
glucose	O
homeostasis	O
,	O
somewhat	O
,	O
through	O
induction	O
of	O
insulin	B-DS
resistance	I-DS
.	O

Mostafalou	O
et	O
al	O
.	O
[	O
23	O
]	O
also	O
found	O
that	O
0	O
.	O
05	O
%	O
Pb	O
level	O
of	O
drinking	O
water	O
could	O
lead	O
to	O
glucose	B-DS
intolerance	I-DS
and	O
insulin	B-DS
resistance	I-DS
in	O
rats	B-OG
.	O

Whereas	O
,	O
overweight	O
itself	O
was	O
a	O
contributing	O
factor	O
to	O
hepatic	O
lipid	O
content	O
and	O
insulin	B-DS
resistance	I-DS
as	O
well	O
as	O
glucose	B-DS
intolerance	I-DS
,	O
all	O
of	O
which	O
could	O
be	O
observed	O
in	O
0	O
.	O
05	O
%	O
Pb	O
received	O
groups	O
,	O
thus	O
it	O
was	O
hard	O
to	O
illustrate	O
whether	O
lead	O
acted	O
mainly	O
as	O
an	O
“	O
obesogen	O
”	O
or	O
directly	O
devoted	O
to	O
insulin	B-DS
resistance	I-DS
.	O

DNA	O
methylation	O
is	O
an	O
important	O
style	O
of	O
epigenetic	O
regulation	O
[	O
24	O
].	O

Previous	O
studies	O
have	O
concentrated	O
on	O
the	O
relationship	O
between	O
Pb	O
exposure	O
and	O
the	O
methylation	O
changes	O
of	O
brain	O
.	O

Developmental	O
Pb	O
exposure	O
not	O
only	O
altered	O
DNA	O
methylation	O
in	O
both	O
specific	O
gene	O
level	O
and	O
global	O
genome	O
level	O
in	O
brain	O
of	O
Alzheimer	B-DS
’	I-DS
s	I-DS
disease	I-DS
model	O
[	O
25	O
–	O
28	O
],	O
but	O
also	O
could	O
affect	O
the	O
expression	O
of	O
DNA	B-GP
methyltransferase	I-GP
1	I-GP
(	O
DNMT1	B-GP
)	O
and	O
DNA	B-GP
methyltransferase	I-GP
3a	I-GP
(	O
DNMT3a	B-GP
)	O
in	O
hippocampus	O
[	O
29	O
].	O

In	O
addition	O
,	O
Pb	O
exposure	O
could	O
enhance	O
the	O
mean	O
DNA	O
methylation	O
level	O
and	O
epigenetic	O
drift	O
of	O
several	O
imprinted	O
genes	O
like	O
IGF	B-GP
-	I-GP
2	I-GP
,	O
Igf2r	B-GP
,	O
H19	B-GP
in	O
both	O
cell	O
model	O
and	O
animal	B-OG
tissues	O
[	O
30	O
,	O
31	O
],	O
although	O
others	O
revealed	O
that	O
increased	O
blood	O
or	O
patella	O
lead	O
levels	O
were	O
associated	O
with	O
hypomethylation	O
of	O
LINE	B-GP
-	I-GP
1	I-GP
in	O
both	O
cell	O
model	O
and	O
population	O
study	O
[	O
32	O
,	O
33	O
].	O

Furthermore	O
,	O
Arko	O
et	O
al	O
.	O
found	O
that	O
Pb	O
exposure	O
during	O
pregnancy	O
affects	O
the	O
DNA	O
methylation	O
status	O
of	O
the	O
fetal	O
germ	O
cells	O
,	O
which	O
led	O
to	O
altered	O
DNA	O
methylation	O
in	O
grandchildren	O
’	O
s	O
neonatal	O
dried	O
blood	O
spots	O
[	O
34	O
].	O

The	O
liver	O
is	O
a	O
critical	O
organ	O
for	O
the	O
regulation	O
of	O
whole	O
body	O
energy	O
homeostasis	O
due	O
to	O
its	O
central	O
role	O
in	O
lipid	O
and	O
glucose	O
metabolism	O
,	O
as	O
well	O
as	O
its	O
close	O
connection	O
via	O
the	O
portal	O
vein	O
to	O
nutrient	O
uptake	O
in	O
the	O
intestine	O
[	O
17	O
].	O

Epigenetic	O
mechanisms	O
may	O
partly	O
explain	O
the	O
pathogenesis	O
and	O
development	O
of	O
metabolic	B-DS
diseases	I-DS
,	O
as	O
previous	O
studies	O
has	O
found	O
altered	O
DNA	O
methylation	O
accompanied	O
by	O
altered	O
transcriptional	O
levels	O
of	O
liver	O
in	O
obesity	B-DS
and	O
type	B-DS
2	I-DS
diabetes	I-DS
.	O

Therefore	O
,	O
we	O
performed	O
a	O
global	O
wide	O
analysis	O
of	O
DNA	O
methylation	O
in	O
liver	O
to	O
explain	O
the	O
mechanism	O
of	O
metabolic	O
changes	O
resulting	O
from	O
adult	O
Pb	O
exposure	O
for	O
the	O
first	O
time	O
.	O

The	O
bisulfite	O
sequencing	O
results	O
revealed	O
a	O
hepatic	O
hypermethylation	O
of	O
whole	O
genome	O
of	O
0	O
.	O
05	O
%	O
Pb	O
exposed	O
rats	B-OG
compared	O
to	O
unexposed	O
ones	O
,	O
which	O
may	O
be	O
explained	O
by	O
changed	O
expression	O
or	O
activity	O
of	O
proteins	O
controlling	O
DNA	O
methylation	O
[	O
18	O
].	O

In	O
addition	O
,	O
a	O
lot	O
of	O
genes	O
involved	O
with	O
glucose	O
and	O
lipid	O
metabolism	O
were	O
observed	O
with	O
apparent	O
DNA	O
methylation	O
alterations	O
at	O
the	O
TSS	O
regions	O
[	O
35	O
].	O

PKB	B-GP
/	O
AKT	B-GP
pathway	O
was	O
essential	O
in	O
regulating	O
lipid	O
and	O
glucose	O
metabolism	O
in	O
liver	O
.	O

Hypermethylation	O
of	O
AKT	B-GP
may	O
result	O
in	O
gene	O
repression	O
and	O
thus	O
inhibiting	O
this	O
pathway	O
,	O
which	O
could	O
lead	O
to	O
reduced	O
glucose	O
uptake	O
and	O
glycogen	O
synthesis	O
but	O
increased	O
gluconeogenesis	O
,	O
thus	O
promoting	O
insulin	B-DS
resistance	I-DS
of	O
liver	O
[	O
17	O
].	O

The	O
hypermethylation	O
of	O
genes	O
involved	O
in	O
fatty	O
acid	O
oxidation	O
such	O
as	O
CPT	B-GP
-	I-GP
2	I-GP
,	O
MCAD	B-GP
,	O
and	O
ACO	B-GP
could	O
result	O
in	O
reduced	O
fatty	O
acid	O
oxidation	O
rate	O
and	O
in	O
turn	O
elevated	O
lipid	O
synthesis	O
in	O
liver	O
.	O

MTTP	B-GP
and	O
lipoprotein	O
like	O
APO	B-GP
-	I-GP
CⅢ	I-GP
,	O
APO	B-GP
-	I-GP
Ⅴ	I-GP
,	O
and	O
APO	B-GP
-	I-GP
Ⅳ	I-GP
were	O
important	O
in	O
VLDL	O
-	O
assembling	O
and	O
TG	O
transportation	O
.	O

Hypermethylation	O
of	O
these	O
proteins	O
may	O
give	O
rise	O
to	O
reduced	O
TG	O
output	O
and	O
a	O
further	O
accumulating	O
of	O
TG	O
in	O
liver	O
[	O
36	O
].	O

Bone	O
lead	O
level	O
is	O
a	O
more	O
reliable	O
biomarker	O
of	O
long	O
-	O
term	O
Pb	O
exposure	O
,	O
while	O
blood	O
lead	O
level	O
reveals	O
recent	O
exposure	O
[	O
15	O
].	O

Thus	O
,	O
we	O
evaluated	O
Pb	O
accumulation	O
by	O
detecting	O
bone	O
lead	O
level	O
instead	O
of	O
blood	O
lead	O
level	O
,	O
which	O
was	O
differed	O
from	O
most	O
previous	O
studies	O
[	O
12	O
,	O
21	O
].	O

Whereas	O
,	O
it	O
would	O
be	O
more	O
rigorous	O
to	O
detect	O
both	O
BLL	O
and	O
bone	O
lead	O
level	O
.	O

Furthermore	O
,	O
the	O
lead	O
level	O
of	O
NCD	O
+	O
0	O
.	O
45	O
%	O
group	O
did	O
not	O
cause	O
corresponding	O
increase	O
in	O
bone	O
lead	O
levels	O
,	O
which	O
may	O
due	O
to	O
the	O
precipitation	O
of	O
the	O
highest	O
concentration	O
of	O
lead	O
in	O
the	O
water	O
.	O

Our	O
study	O
has	O
some	O
merits	O
.	O

Firstly	O
,	O
for	O
the	O
first	O
time	O
,	O
we	O
performed	O
whole	O
genome	O
DNA	O
methylation	O
analysis	O
of	O
liver	O
in	O
both	O
Pb	O
exposure	O
rats	B-OG
and	O
control	O
rats	B-OG
,	O
in	O
order	O
to	O
explore	O
the	O
potential	O
mechanism	O
of	O
metabolic	O
changes	O
after	O
exposure	O
to	O
lead	O
.	O

Secondly	O
,	O
our	O
study	O
concentrated	O
on	O
adult	O
stage	O
but	O
not	O
prenatal	O
or	O
developmental	O
stage	O
.	O

This	O
made	O
good	O
sense	O
in	O
our	O
daily	O
life	O
,	O
because	O
the	O
metabolic	B-DS
disorder	I-DS
and	O
altered	O
DNA	O
methylation	O
of	O
adults	O
may	O
have	O
adverse	O
effects	O
on	O
the	O
next	O
generation	O
.	O

In	O
conclusion	O
,	O
we	O
found	O
that	O
chronic	O
0	O
.	O
05	O
%	O
Pb	O
exposure	O
results	O
in	O
dose	O
-	O
specific	O
insulin	B-DS
resistance	I-DS
and	O
weight	O
gain	O
.	O

These	O
metabolic	B-DS
disorders	I-DS
may	O
be	O
induced	O
through	O
altered	O
methylation	O
of	O
genes	O
related	O
with	O
metabolism	O
.	O

Further	O
studies	O
are	O
warranted	O
to	O
explore	O
the	O
alteration	O
of	O
specific	O
gene	O
expression	O
and	O
its	O
association	O
with	O
DNA	O
methylation	O
in	O
both	O
animal	B-OG
and	O
cellular	O
levels	O
.	O

Supporting	O
Information	O

The	O
density	O
distribution	O
curves	O
of	O
methylated	O
CG	O
sites	O
.	O

(	O
a	O
)(	O
b	O
)	O
NCD	O
+	O
0	O
.	O
05	O
%;	O
(	O
c	O
)(	O
d	O
)	O
NCD	O
.	O

(	O
TIF	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Average	O
DNA	O
methylation	O
levels	O
in	O
specific	O
Genetic	O
functional	O
elements	O
.	O

(	O
a	O
)(	O
b	O
)	O
NCD	O
+	O
0	O
.	O
05	O
%;	O
(	O
c	O
)(	O
d	O
)	O
NCD	O
.	O

(	O
TIF	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Differential	O
methylated	O
genes	O
.	O

proportion1	O
:	O
NCD	O
;	O
proportion2	O
:	O
NCD	O
+	O
0	O
.	O
05	O
%	O
Pb	O
.	O

(	O
XLS	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

